Blood cancers, Cell type, Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 3
This trial was to see if long term treatment with rituximab helped people who had responded to a combination of chemotherapy and rituximab as for follicular lymphoma. This trial was supported by Cancer Research UK.
Recruitment start: 1 December 2004
Recruitment end: 30 April 2007
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Andrew Lister
Cancer Research UK
GELA
National Institute for Health Research Cancer Research Network (NCRN)
This is Cancer Research UK trial number CRUKE/05/026.
Last reviewed: 20 October 2010
CRUK internal database number: 602
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
